2014 Q3 Form 10-Q Financial Statement

#000137371514000151 Filed on August 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2013 Q2
Revenue $178.7M $166.8M $102.2M
YoY Change 60.63% 63.13% 80.05%
Cost Of Revenue $66.09M $58.94M $36.00M
YoY Change 58.96% 63.73% 57.26%
Gross Profit $112.6M $107.8M $66.22M
YoY Change 61.62% 62.81% 95.45%
Gross Profit Margin 63.02% 64.66% 64.78%
Selling, General & Admin $107.4M $116.9M $67.62M
YoY Change 69.16% 72.82% 100.47%
% of Gross Profit 95.4% 108.38% 102.1%
Research & Development $39.68M $35.44M $17.95M
YoY Change 90.61% 97.42% 93.6%
% of Gross Profit 35.23% 32.87% 27.11%
Depreciation & Amortization $9.329M $8.228M $5.322M
YoY Change 51.59% 54.61% 88.35%
% of Gross Profit 8.28% 7.63% 8.04%
Operating Expenses $147.1M $152.3M $85.57M
YoY Change 74.46% 77.98% 98.99%
Operating Profit -$34.50M -$44.47M -$19.34M
YoY Change 135.49% 129.91% 112.16%
Interest Expense -$5.900M -$5.200M -$1.300M
YoY Change -1083.33% 300.0%
% of Operating Profit
Other Income/Expense, Net -$5.949M -$5.231M -$1.323M
YoY Change -1091.5% 295.39% -3326.83%
Pretax Income -$40.45M -$49.70M -$20.67M
YoY Change 187.89% 140.5% 127.7%
Income Tax $602.0K $661.0K $739.0K
% Of Pretax Income
Net Earnings -$41.05M -$50.36M -$21.41M
YoY Change 179.0% 135.29% 145.36%
Net Earnings / Revenue -22.97% -30.2% -20.94%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$280.9K -$348.8K -$0.16
COMMON SHARES
Basic Shares Outstanding 145.7M shares 134.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $646.1M $677.5M $253.8M
YoY Change 193.55% 166.94% 187.43%
Cash & Equivalents $235.1M $329.3M $120.2M
Short-Term Investments $411.0M $348.2M $133.5M
Other Short-Term Assets $64.20M $57.90M $30.30M
YoY Change 70.29% 91.09% 83.64%
Inventory
Prepaid Expenses
Receivables $111.2M $109.2M $92.80M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $821.4M $844.7M $376.8M
YoY Change 139.88% 124.16% 147.74%
LONG-TERM ASSETS
Property, Plant & Equipment $96.98M $96.48M $57.25M
YoY Change 41.28% 68.52% 61.28%
Goodwill $58.34M $8.622M
YoY Change 584.31%
Intangibles $58.30M $5.290M
YoY Change 842.06%
Long-Term Investments $238.1M $279.6M $92.30M
YoY Change 79.56% 202.93%
Other Assets $6.218M $5.125M $2.143M
YoY Change 71.53% 139.15% -83.39%
Total Long-Term Assets $483.2M $417.6M $165.5M
YoY Change 104.48% 152.28% 241.99%
TOTAL ASSETS
Total Short-Term Assets $821.4M $844.7M $376.8M
Total Long-Term Assets $483.2M $417.6M $165.5M
Total Assets $1.305B $1.262B $542.3M
YoY Change 125.42% 132.74% 170.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.42M $22.46M $10.02M
YoY Change 43.96% 124.27% 16.47%
Accrued Expenses $69.41M $64.30M $46.79M
YoY Change 39.76% 37.41% 152.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M
YoY Change
Total Short-Term Liabilities $419.3M $403.0M $249.2M
YoY Change 56.37% 61.75% 64.14%
LONG-TERM LIABILITIES
Long-Term Debt $436.3M $429.0M $0.00
YoY Change
Other Long-Term Liabilities $19.24M $19.49M $7.591M
YoY Change 148.47% 156.74% -67.42%
Total Long-Term Liabilities $19.24M $19.49M $7.591M
YoY Change 148.47% 156.74% -67.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $419.3M $403.0M $249.2M
Total Long-Term Liabilities $19.24M $19.49M $7.591M
Total Liabilities $887.2M $864.1M $274.4M
YoY Change 204.73% 214.87% 56.73%
SHAREHOLDERS EQUITY
Retained Earnings -$313.9M -$272.9M -$140.3M
YoY Change 102.58% 94.56%
Common Stock $737.7M $670.4M $410.0M
YoY Change 66.43% 63.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $417.4M $398.1M $267.9M
YoY Change
Total Liabilities & Shareholders Equity $1.305B $1.262B $542.3M
YoY Change 125.42% 132.74% 170.49%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$41.05M -$50.36M -$21.41M
YoY Change 179.0% 135.29% 145.36%
Depreciation, Depletion And Amortization $9.329M $8.228M $5.322M
YoY Change 51.59% 54.61% 88.35%
Cash From Operating Activities $25.00M $42.10M $9.800M
YoY Change 20.77% 329.59% 42.03%
INVESTING ACTIVITIES
Capital Expenditures -$18.10M -$16.40M -$11.80M
YoY Change 7.1% 38.98% 1.72%
Acquisitions $100.0M
YoY Change
Other Investing Activities -$122.9M -$40.60M -$33.60M
YoY Change 517.59% 20.83% 342.11%
Cash From Investing Activities -$141.0M -$57.00M -$45.40M
YoY Change 284.2% 25.55% 136.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.70M 6.200M 11.10M
YoY Change 67.97% -44.14% -716.67%
NET CHANGE
Cash From Operating Activities 25.00M 42.10M 9.800M
Cash From Investing Activities -141.0M -57.00M -45.40M
Cash From Financing Activities 25.70M 6.200M 11.10M
Net Change In Cash -90.30M -8.700M -24.50M
YoY Change 12800.0% -64.49% 73.76%
FREE CASH FLOW
Cash From Operating Activities $25.00M $42.10M $9.800M
Capital Expenditures -$18.10M -$16.40M -$11.80M
Free Cash Flow $43.10M $58.50M $21.60M
YoY Change 14.63% 170.83% 16.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
22463000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7405000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2233000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3859000 USD
CY2014Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
13629000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
16610000 USD
CY2014Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
64297000 USD
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
68130000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68130000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64297000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38107000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51608000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-242000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
148000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-234000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
452000 USD
us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P52M
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
163000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-476000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
600000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
670242000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
573791000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1100000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1700000 USD
CY2014Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6816000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13517000 USD
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
11997000 USD
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
23635000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
766000 USD
CY2014Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
386000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
14283000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2014Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7202000 USD
CY2013Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
468000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
908000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31815977 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43528622 shares
CY2013Q4 us-gaap Assets
Assets
1168476000 USD
CY2014Q2 us-gaap Assets
Assets
1262243000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
844659000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
797749000 USD
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
627785000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
523607000 USD
CY2014Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
627637000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
523849000 USD
CY2013 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
381000 USD
us-gaap Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
193000 USD
CY2014Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
288866000 USD
CY2013Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
375109000 USD
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
268251000 USD
CY2014Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
348205000 USD
CY2014Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
348205000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2098000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
341000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
139000 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
193000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
381000 USD
CY2013Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
255356000 USD
CY2014Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
279580000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12669000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5756000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366303000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
329275000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120233000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118989000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-37028000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1244000 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
107.46
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7800000 shares
CY2014Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
51147992 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
145174006 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
140000 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
145000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92598000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22081000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36559000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49487000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments potentially exposing us to credit risk consist primarily of cash equivalents, investments and accounts receivable. We maintain cash, cash equivalents and investments at financial institutions that management believes to have good credit ratings and represent minimal risk of loss of principal. We invest in securities issued by financial-sector firms with a minimum rating of A by Standard &amp; Poor's and A2 by Moody's and securities issued by non-financial sector firms with a minimum rating of BBB by Standard &amp; Poor's and Baa1 by Moody's.</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit risk arising from accounts receivable is mitigated due to our large number of customers and their dispersion across various industries and geographies. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> customers that represented more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of our accounts receivable balance. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> customers that individually exceeded </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of our revenues.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We review the composition of the accounts receivable balance, historical write-off experience and the potential risk of loss associated with delinquent accounts to determine if an allowance for doubtful accounts is necessary. Individual accounts receivable are written off when we become aware of a specific customer&#8217;s inability to meet its financial obligation and all collection efforts are exhausted. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, the allowance for doubtful accounts was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">, res</font></div></div>
CY2014Q2 us-gaap Convertible Debt
ConvertibleDebt
429025000 USD
CY2013Q4 us-gaap Convertible Debt
ConvertibleDebt
414777000 USD
CY2013Q2 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
20219000 USD
us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
64432000 USD
CY2014Q2 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
33243000 USD
us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
38531000 USD
us-gaap Cost Of Revenue
CostOfRevenue
112052000 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
58938000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
35998000 USD
us-gaap Cost Of Revenue
CostOfRevenue
68306000 USD
CY2014Q2 us-gaap Cost Of Services
CostOfServices
25695000 USD
us-gaap Cost Of Services
CostOfServices
47620000 USD
CY2013Q2 us-gaap Cost Of Services
CostOfServices
15779000 USD
us-gaap Cost Of Services
CostOfServices
29775000 USD
CY2013Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
73.88
us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
13.54
us-gaap Debt Instrument Convertible Earliest Date1
DebtInstrumentConvertibleEarliestDate1
2014-03-31
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
7800000 shares
us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
July 1, 2018
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
575000000 USD
CY2014Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
575000000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
575000000 USD
CY2014Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.065
CY2013Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2018-11-01
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
160223000 USD
CY2014Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
145975000 USD
CY2013Q4 us-gaap Deferred Costs
DeferredCosts
21318000 USD
CY2014Q2 us-gaap Deferred Costs
DeferredCosts
22484000 USD
CY2013Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
31123000 USD
CY2014Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
34105000 USD
CY2013Q4 us-gaap Deferred Revenue And Credits
DeferredRevenueAndCredits
14169000 USD
CY2014Q2 us-gaap Deferred Revenue And Credits
DeferredRevenueAndCredits
12565000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
252553000 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
316287000 USD
us-gaap Depreciation
Depreciation
9650337 USD
CY2013Q2 us-gaap Depreciation
Depreciation
5321644 USD
us-gaap Depreciation
Depreciation
15716641 USD
CY2014Q2 us-gaap Depreciation
Depreciation
8227768 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16630000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9703000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-21000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-806000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.04
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.04
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19754000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22322000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M18D
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
59100000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2571000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
617000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
2571000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
617000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1889000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
985000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7179000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6781000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5290000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5796000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46545000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15325000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27604000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24914000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
8724000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
8622000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-102000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
107819000 USD
us-gaap Gross Profit
GrossProfit
193795000 USD
us-gaap Gross Profit
GrossProfit
119855000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
66224000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-49702000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33460000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-91846000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20666000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
661000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1303000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
739000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1828000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-125000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10976000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6206000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1000000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
27966000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
20780000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
63312000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40574000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5595000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1101000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
15891000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
55000 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5290000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5796000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
864126000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
774217000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1168476000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1262243000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
328088000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
403047000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33703000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29428000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132711000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56412000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24759000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66276000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34763000 USD
us-gaap Net Income Loss
NetIncomeLoss
-93674000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-21405000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-50363000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34763000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50363000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-93674000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21405000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-93674000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21405000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-50363000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-34763000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
75560000 USD
CY2014Q2 us-gaap Noncurrent Assets
NoncurrentAssets
96483000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5231000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1323000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1204000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11194000 USD
us-gaap Operating Expenses
OperatingExpenses
274447000 USD
us-gaap Operating Expenses
OperatingExpenses
152111000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
85567000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
152290000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44471000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-80652000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19343000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-32256000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3973000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5125000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
511000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1367000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-201000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
686000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-676000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1076000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1796000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
876000 USD
CY2013Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
11926000 USD
CY2014Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
14201000 USD
CY2014Q2 us-gaap Other Liabilities
OtherLiabilities
13002000 USD
CY2013Q4 us-gaap Other Liabilities
OtherLiabilities
13085000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19489000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17183000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1590000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
913000 USD
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
135800000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
241312000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
184763000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27405000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22235000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23828000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23733000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31830000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28811000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
84500000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-698000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
67168000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
107451000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
68893000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
43298000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
148091000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
113667000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96483000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75560000 USD
CY2014Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
109246000 USD
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
108339000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33990000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66549000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35439000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17951000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179196000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-272870000 USD
CY2014Q2 us-gaap Revenues
Revenues
166757000 USD
CY2013Q2 us-gaap Revenues
Revenues
102222000 USD
us-gaap Revenues
Revenues
188161000 USD
us-gaap Revenues
Revenues
305847000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
166757000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
305847000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
102222000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
188161000 USD
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
34033000 USD
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
21846000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
55748000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
36227000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M21D
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
161353000 USD
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
91937000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52291000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
90517000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
66833000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
37604000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26874000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
14828000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9616984 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
209315000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
232048 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.48
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1006664000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19375640 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23399374 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.05
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.07
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
994766000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
19089638 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.85
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.35
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
64.82
CY2013Q4 us-gaap Share Price
SharePrice
56.01
CY2014Q2 us-gaap Share Price
SharePrice
61.96
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
534804000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M9D
CY2014Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3711000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4187000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-429000 USD
CY2014Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
365000 USD
CY2013Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-475000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
390000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M5D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
21300000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3792101 shares
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
398117000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
394259000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </font></div></div>
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
600000 USD
CY2014Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1000000 USD
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
144456675 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
134454085 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
132298095 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
143267181 shares
now Available For Sale Securities In Gross Unrealized Loss Position Maturities Term Maximum
AvailableForSaleSecuritiesInGrossUnrealizedLossPositionMaturitiesTermMaximum
P12M
now Available For Sale Securities Maturities Term Maximum
AvailableForSaleSecuritiesMaturitiesTermMaximum
P24M
CY2014Q2 now Availableforsale Securities Debt Maturities Year Two Through Three Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
279580000 USD
now Conversion Of Notes Base Conversion Price
ConversionOfNotesBaseConversionPrice
1000 USD
CY2014Q2 now Maximum Percentof Target Awardof Stock Plan
MaximumPercentofTargetAwardofStockPlan
2
CY2014Q2 now Minimum Percentof Target Awardof Stock Plan
MinimumPercentofTargetAwardofStockPlan
0
now Note Hedged Shares Of Common Stock Covered
NoteHedgedSharesOfCommonStockCovered
7800000 shares
CY2013Q4 now Number Of Customer Accounted On Accounts Receivable Balance
NumberOfCustomerAccountedOnAccountsReceivableBalance
0 Customer
CY2014Q2 now Number Of Customer Accounted On Accounts Receivable Balance
NumberOfCustomerAccountedOnAccountsReceivableBalance
0 Customer
now Number Of Shares Cancelled
NumberOfSharesCancelled
463681 shares
now Percentage Of Purchase Price Of Notes Which Should Be Paid Upon Fundamental Change
PercentageOfPurchasePriceOfNotesWhichShouldBePaidUponFundamentalChange
1.00
now Percentage Of Revenue
PercentageOfRevenue
0.1
now Percentage Of Revenues Customers Exceeded Individually
PercentageOfRevenuesCustomersExceededIndividually
0.1
now Percentageof U.S.Revenuesin North America
PercentageofU.S.RevenuesinNorthAmerica
0.94
now Percentageof U.S.Revenuesin North America
PercentageofU.S.RevenuesinNorthAmerica
0.94
CY2013Q2 now Percentageof U.S.Revenuesin North America
PercentageofU.S.RevenuesinNorthAmerica
0.94
CY2014Q2 now Percentageof U.S.Revenuesin North America
PercentageofU.S.RevenuesinNorthAmerica
0.94
CY2014Q2 now Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Estimated Percentageof Performance Goal Target Earned
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsEstimatedPercentageofPerformanceGoalTargetEarned
1.229
now Subscription Revenues
SubscriptionRevenues
250099000 USD
CY2014Q2 now Subscription Revenues
SubscriptionRevenues
132724000 USD
CY2013Q2 now Subscription Revenues
SubscriptionRevenues
80376000 USD
now Subscription Revenues
SubscriptionRevenues
151934000 USD
now Weighted Average Exercise Price Cancelled
WeightedAverageExercisePriceCancelled
24.47
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001373715
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145700000 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SERVICENOW, INC.
dei Trading Symbol
TradingSymbol
NOW

Files In Submission

Name View Source Status
0001373715-14-000151-index-headers.html Edgar Link pending
0001373715-14-000151-index.html Edgar Link pending
0001373715-14-000151.txt Edgar Link pending
0001373715-14-000151-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
now-20140630.xml Edgar Link completed
now-20140630.xsd Edgar Link pending
now-20140630_cal.xml Edgar Link unprocessable
now-20140630_def.xml Edgar Link unprocessable
now-20140630_lab.xml Edgar Link unprocessable
now-20140630_pre.xml Edgar Link unprocessable
now-2014630x10q.htm Edgar Link pending
now-2014630xex101.htm Edgar Link pending
now-2014630xex311.htm Edgar Link pending
now-2014630xex312.htm Edgar Link pending
now-2014630xex321.htm Edgar Link pending
now-2014630xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sncrlogostandarda01a01.jpg Edgar Link pending